Hiv therapeutic vaccine enhances non-exhausted cd4+ t cells in a randomised phase 2 trial

HIGHLIGHTS

• who: Vincent Vieillard from the (UNIVERSITY) have published the research work: HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial, in the Journal: (JOURNAL) of 14/Dec/2018
• what: The trial was conducted was conducted in clinical centres in France, Spain, and Germany in accordance with Good Clinical Practices and the ethical principles of the Helsinki declaration.
• how: Data were analyzed with Flow Jo version 9 (TreeStar).
• future: These encouraging results of VAC-3S not only warrant optimisation of the vaccine strategy but also strongly . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.